Discontinued — last reported Q1 '26
Merck & Co. Animal Health — SG&A decreased by 7.2% to $282.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.5%, from $260.00M to $282.00M. Over 3 years (FY 2022 to FY 2025), Animal Health — SG&A shows an upward trend with a 4.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
High spending may be necessary for growth, but excessive spending relative to revenue can signal operational inefficiency.
Operating expenses related to marketing, sales force, and administrative support for the animal health segment. This ref...
Standard SG&A metric for operating segments across all industries.
mrk_segment_animal_health_selling_general_and_administrative| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $249.75M | $249.75M | $249.75M | $249.75M | $259.50M | $259.50M | $259.50M | $259.50M | $252.00M | $270.00M | $268.00M | $294.00M | $260.00M | $284.00M | $277.00M | $304.00M | $282.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +3.9% | +0.0% | +0.0% | +0.0% | -2.9% | +7.1% | -0.7% | +9.7% | -11.6% | +9.2% | -2.5% | +9.7% | -7.2% |
| YoY Change | — | — | — | — | +3.9% | +3.9% | +3.9% | +3.9% | -2.9% | +4.0% | +3.3% | +13.3% | +3.2% | +5.2% | +3.4% | +3.4% | +8.5% |